DocBuzz, Inc., a medical marketing firm, specializes in medical device detailing, pharmaceutical, and biotechnical. DocBuzz, Inc., a company that is exclusively for doctors and the medical community, is the only one of its kind. DocBuzz, Inc. was founded and managed by practicing physicians.
With revenues in excess of $96.3 million annually, the pharmaceutical industry is one of most profitable. The problem facing the pharmaceutical sector is simply time. Time to research and develop, time for branding and marketing, time for sales and time to gain the trust of the medical profession. In this industry, we can equate time with money.
There are also two industries that have similar problems with their products. These are biotech companies and medical device firms. These companies have to compete with other industries for their revenues, even though the revenue is not as high as the pharmaceutical industry.
DocBuzz, Inc., developed a method that allows these industries to benefit prelaunch marketing, product brand, and postlaunch sales support. All this was done with the direct involvement of physicians. DocBuzz, Inc., gives the client companies the opportunity to market directly to the decision makers, establishing immediate credibility through our extensive network of physicians and other medical professionals. Our eÂdetailing is the most cost-effective option of all services. Live conferences are available, 24 hours per day, seven days a săptămână. This service provides access to an array of current information, including new biotech developments, pharmaceutical products and medical devices.
DocBuzz, Inc., will serve the marketing needs of the medical device, biotech, pharmaceutical and biotech industries. Our physicians have direct access to us and we can also provide our services. We can deliver these companies’ message directly to the decision makers for 75% of what these industries are currently budgeting. In addition, DocBuzz, Inc., by virtue of its unique incentive program will allow additional revenue to participating physicians and other medical practitioners.
DocBuzz’s winning strategy is to give the best and most accurate information to the medical professionals. The industry can also use DocBuzz to promote, market and advertise their products through highly respected doctors. Individual medical professionals benefit by being able to access the most recent industry information via the Internet. Additionally, at the end the e-detailing will allow them to request samples, additional information about the product, or to have a representative from a pharmaceutical company visit. Professionals on our medical panel can earn points by participating in our e-detailing and/or by referral of others who join our program.
1.1 Keys to Success
DocBuzz, Inc., identified four key strategies that are critical to our success.
- To increase market acceptance of a product, and its prescribing patterns, the Internet technology was developed to improve the access of the prescribing physician to the pharmaceuticals.
- DocBuzz, Inc. uses a grass-root approach to recruit and keep participating prescribing physicians through a value referral program (VIRP). DocBuzz, Inc., as a physician owned and operated company, understands physician’s needs and offers, in addition to our unique VIRP system, other value added programs such as CME, physician cyber meeting places and other extensive point redemption options.
- DocBuzz, Inc. can provide evidence-based analysis for the pharmaceutical industry in order to justify the pharmaceutical investment in e-detailing.
- DocBuzz, Inc., expects to experience rapid, but controlled, growth in order for us to keep our quality service.
1.2 Mission
DocBuzz, Inc., is a reliable, high-quality option to in-house resources. DocBuzz, Inc., helps to increase the return on marketing and sales investment by expediting the physician learning curve regarding prelaunch, new, existing and postlaunch products. It also provides access via the Internet to educational details and market research. DocBuzz, Inc., also benefits small, innovative biotechnology and pharmaceutical businesses that do not have a strong North American sales force.